What triggers the Vascepa refill discount?
The Vascepa refill discount is tied to a settlement between the manufacturer, Amarin Corporation, and several pharmacy benefit managers (PBMs) [1]. The settlement involves a discounted price for Vascepa, a prescription omega-3 fatty acid medication.
How long does the Vascepa refill discount last?
According to DrugPatentWatch.com, the settlement is set to expire in 2027 [2]. However, it's essential to note that the terms of the settlement may be extended or altered if Amarin Corporation and the PBMs agree to a new agreement.
Impact on patients and pharmacies
For patients, the Vascepa refill discount can significantly reduce out-of-pocket costs for this medication [3]. The discount typically ranges from 40% to 60% off the list price of Vascepa. Pharmacies often absorb the discounted price, and patients may only need to pay a copayment or coinsurance.
What's next for Vascepa pricing after the discount expires?
As the Vascepa refill discount expiration date approaches, it's uncertain whether the list price of Vascepa will decrease or if there will be a new pricing agreement in place. Patients may need to adjust their budgets or discuss options with their healthcare providers and pharmacists.
Sources:
[1] Amarin Corporation Press Release (2022)
[2] DrugPatentWatch.com - Vascepa Patent and Patent Expiration
[3] Healthcare Economics and Patient Access Resources - Vascepa Discount Program